Health · 1 sources covering this

STAT+: Caribou Biosciences, biotech co-founded by Jennifer Doudna, is shutting down

Caribou Biosciences is shutting down after failing to raise the money necessary to fund a late-stage clinical trial of its off-the-shelf CAR-T therapy for lymphoma.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·1h ago
STAT+: Caribou Biosciences, biotech co-founded by Jennifer Doudna, is shutting down
Caribou Biosciences is shutting down after failing to raise the money necessary to fund a late-stage clinical trial of its off-the-shelf CAR-T therapy for lymphoma.
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/bf93930e3d7ce7df2e457d7c2012d52a3d5a6082"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Caribou Biosciences, biotech co-founded by Jennifer Doudna, is shutting down"></iframe>

STAT+: Caribou Biosciences, biotech co-founded by Jennifer Doudna, is shutting down

How 1 sources are covering this

STAT+: Caribou Biosciences, biotech co-founded by Jennifer Doudna, is shutting down

More from Health

Food Aid Enrollment Tanks After SNAP Rule Changes

‘Medicare for All’ Message Attracts Voters Buckling Under Medical Bills

Opinion: My oncologist recommended active surveillance for prostate cancer. Life insurers called it ‘untreated cancer’

STAT+: Democrats plot a midterms push for MAHA voters

Reader

Trust & legal

Across the network